excluder
A Qualtrics data-cleaning package that has been in maintenance mode since its CRAN acceptance.
Comparison · Analytics
DoseFinding vs pharmaverseadam
A side-by-side editorial comparison of DoseFinding and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.
DoseFinding vs pharmaverseadam: at a glance
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
What is pharmaverseadam?
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
DoseFinding vs pharmaverseadam: editorial side-by-side
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
pharmaverseadam
0.0ANALYTICS
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
◆ Current state
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
◆ Where it's heading
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
◆ Prediction
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
Alternatives to DoseFinding and pharmaverseadam
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or pharmaverseadam.
geotargets
Geospatial targets grew from two raster helpers into a tiling and multi-backend pipeline layer.
forcis
A foraminifera data-access package whose entire release history is the rOpenSci review process.
daiquiri
A data-quality report generator that finished its API rewrite and has been coasting on small features since.
r2rtf
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
webmockr
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
See all DoseFinding alternatives → · See all pharmaverseadam alternatives →
Recent activity from DoseFinding and pharmaverseadam
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 5mo agopharmaverseadamNeurology and anti-drug antibody datasets added
- 11mo agopharmaverseadamMetabolic therapeutic area datasets arrive
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agopharmaverseadamPediatric ADVS added in an ad-hoc refresh
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agopharmaverseadam1.0 declares the dataset collection stable
- 2y agoDoseFindingCompliance update for R-devel
- 2y agopharmaverseadamFirst release of the ADaM dataset collection
- 3y agoDoseFindingpowMCTBinCount bug fix
Frequently asked questions
What is the difference between DoseFinding and pharmaverseadam?
They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is DoseFinding better than pharmaverseadam?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.
What are the best alternatives to pharmaverseadam?
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.